![Sudha Parasuraman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sudha Parasuraman
Hoofd Techniek/Wetenschap/O&O bij Ribon Therapeutics, Inc.
Profiel
Sudha Parasuraman is an Independent Director at Terray Therapeutics, Inc. and the Chief Medical Officer at Ribon Therapeutics, Inc. She holds a doctorate degree from the University of Madras.
Actieve functies van Sudha Parasuraman
Bedrijven | Functie | Begin |
---|---|---|
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | Directeur/Bestuurslid | 16-05-2023 |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Sudha Parasuraman
University of Madras | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Terray Therapeutics, Inc.
![]() Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Terray Therapeutics, Inc. operates as a biotechnology company. It utilizes a novel spatially encoded screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease .The company was founded by Jacob Berlin, Gregory Copeland and Eli Berlin and is headquartered in Pasadena, CA. | Commercial Services |
Ribon Therapeutics, Inc.
![]() Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Health Technology |